Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin.

about

Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin.

Item

http://www.wikidata.org/entity/Q47342428

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Model-Based Evaluation of Prox ...... Inhibition With Canagliflozin.

@en

Model-Based Evaluation of Prox ...... Inhibition With Canagliflozin.

@nl

type

Item

label

Model-Based Evaluation of Prox ...... Inhibition With Canagliflozin.

@en

Model-Based Evaluation of Prox ...... Inhibition With Canagliflozin.

@nl

prefLabel

Model-Based Evaluation of Prox ...... Inhibition With Canagliflozin.

@en

Model-Based Evaluation of Prox ...... Inhibition With Canagliflozin.

@nl

P1476

Model-Based Evaluation of Prox ...... Inhibition With Canagliflozin

@en

P2093

Jessica A Brady

http://www.w3.org/2001/XMLSchema#string

K Melissa Hallow

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics.

Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view.

Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes.

Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron.

Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.

Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes.

SGLT2 Inhibitors and the Diabetic Kidney.

Pharmacokinetics and pharmacodynamics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in subjects with type 2 diabetes mellitus.

An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations.

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

P304

377-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.1030

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

K Melissa Hallow

Jessica A Brady

P577

2017-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29144539

http://www.w3.org/2001/XMLSchema#string